Cost-Effectiveness Analysis of Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in the United States
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1595
https://www.valueinhealthjournal.com/article/S1098-3015(16)01663-6/fulltext
Title :
Cost-Effectiveness Analysis of Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01663-6&doi=10.1016/j.jval.2016.03.1595
First page :
A151
Section Title :
Cancer - Cost Studies
Open access? :
No
Section Order :
318